Trial intelligence / Profile preview

Tranexamic acid for hemostasis in elderly PFNA surgery

ChiCTR-IPR-17011260Phase 4Not yet recruiting

Sponsor
Clinical Medical College of Yangzhou University
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tranexamic acid in intertrochanteric fracture, sponsored by Clinical Medical College of Yangzhou University. Primary endpoints: Total blood loss, Intraoperative blood loss and 4 more. Planned start May 2017; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

intertrochanteric fracture

Beyond the preview

Go deeper on ChiCTR-IPR-17011260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call